Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL)

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1023-1033

  Smith, Pamela A ^a,b   Brunmark, Anders ^c   Jackson, Michael R ^c   Potter, Terry A ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CELL CLONING; CELL ISOLATION; CELL LINE; CELL TRANSPORT; CYTOTOXIC T LYMPHOCYTE; DROSOPHILA MELANOGASTER; HUMAN; HUMAN CELL; HYPOTHESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SKIN GRAFT;

ANIMALS; CELL LINE; CLONE CELLS; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; DROSOPHILA MELANOGASTER; H-2 ANTIGENS; HYBRIDOMAS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, TRANSGENIC; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0030989505     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1023     Document Type: Article

References (56)

1. Kourilsky, P., and J.M. Claverie. 1989. MHC-antigen interaction: what does the T cell receptor see? Adv. Immunol. 45: 107-193.
2. Catipovic. B., J. Dal Porto, M. Mage, T.E. Johansen, and J.P. Schnech. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611-1618.
3. Bluestone, J.A., S. Jameson, S. Miller, and R. Dick II. 1992. Peptide-induced conformational changes in Class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757-1761.
4. Bevan, M.J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today. 5:128-130.
5. Guimezanes, A., T.N.M. Schumacher, H.L. Ploegh, and A.-M. Schmitt-Verhulst. 1992. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Eur. J. Immunol. 22:1651-1654.
6. Heath, W.R., K.P. Kane, M.F. Mescher, and L.A. Sherman. 1991. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Prof. Natl. Acad. Sci. USA. 88:5101-5105.
7. Heath, W.R., and L.A. Sherman. 1991. Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur. J. Immunol. 21:153-159.
8. Sherman, L.A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385-402.
9. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell. 69:989-998.
10. Alexander-Miller, M.A., K. Burke, U.H. Koszinowski, T.H. Hansen, and J.M. Connolly. 1993. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J. Immunol. 151:1-10.
11. Marrack, P., and J. Kappler. 1988. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature (Lond.). 332:840-843.
12. Crumpacker, D.B., J. Alexander, P. Cresswell, and V.H. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J. Immunol. 148:3004-3011.
13. Aosai, F., C. Ohlen, H.-G. Ljunggren, P. Hoglund, L. Franksson, H. Ploegh, A. Townsend, K. Karre, and H.J. Stauss. 1991. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur. J. Immunol. 21:2767-2774.
14. Man, S., R.D. Salter, and V. Engelhard, H. 1992. Role of endogenous peptide in human alloreactive cytotoxic T cell responses. Intl. Immunol. 4:367-375.
15. Rotzschke, O., K. Falk, S. Faath, and H.-G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059-1071.
16. Elliott, T.J., and H.N. Eisen. 1990. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad. Sci. USA. 87: 5213-5217.
17. Henderson, R.A., M. Hanspeter, K. Sakaguchi, J. Shabanowitz, E. Appella, D.F. Hunt, and V.H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (Wash. DC). 255: 1264-1266.
18. Wei, M.L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (Lond.). 356:443-446.
19. Zweerink, H.J., M.C. Gammon, U. Utz, S.Y. Sauma, T. Harrer, J.C. Hawkins, P.R. Johnson, A. Sirotina, J.D. Hermes, B.D. Walker, and W.E. Biddison. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763-1771.
20. Zhou, X., R. Glas, F. Momburg, G.J. Hammerling, M. Jondal, and H.-G. Ljunggren. 1993. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23:1796-1801.
21. Hosken, N.A., and M.J. Bevan. 1992. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J. Exp. Med. 175:719-729.
22. Sijts, A.J.A.M., M.L.H. De Bruijn, J.D. Nieland, K.W. Martin, and C.J.M. Melief. 1992. Cytotoxic T lymphocytes against the antigen-processing-defective RMA-s tumor cell line. Eur. J. Immunol. 22:1639-1642.
23. Esquivel, F., J. Yewdell, and J. Bennink. 1992. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175:163-168.
24. Ingold, A.L., C. Landel, C. Knall, G.A. Evans, and T.A. Potter. 1991. Co-engagement of CD8 with the T cell receptor is required for negative selection. Nature (Lond.). 352:721-723.
25. Glimcher, L.H., D.J. McKean, E. Choi, and J.G. Seidman. 1985. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J. Immunol. 135:3542-3550.
26. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (Lond.). 449:345-352.
27. Salter, R.D., D.N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:235-246.
28. Ljunggren, H.-G., N.J. Stam, C. Ohlen, J. Neefjes, J., P. Hoglund, M.-T. Heemels, J. Bastin, T.N.M. Schumacher, A. Townsend, K. Karre, and H.L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature (Lond.). 346: 476-480.
29. Schumacher, T.N.M., M.-T. Heemels, J.J. Neefjes, W.M. Kast, C.J.M. Melief, and H.L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 62:563-567.
30. Townsend, A., C. Ohlen, J. Bastin, L. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond.). 340:443-448.
31. Potter, T.A., R.F. Rajan, R.F. Dick II, and J.A. Bluestone. 1989. Substitution at residue 227 or H-2 class I molecules abrogates recognition by CD8-dependent, cytotoxic T lymphocytes. Nature (Lond.). 337:73-75.
32. Caligan, J.E., A.M. Kruisbeck, D.H. Marguhes, E.M. Shevack, and I. Strober. 1994. Curr. Prot. Immunol. 178:713-722.
33. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/ MHC-specific T cell hybrids. Intl. Immunol. 6:369-376.
34. Storkus, W.J., H.J. Zeh III, R.D. Salter, and M.T. Lotze. 1993. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunotherapy. 14:94-103.
35. Sykulev, Y., A. Brunmark, M. Jackson, R.J. Cohen, P.A. Peterson, and H.N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity. 1:15-22.
36. b-restricted ovalbumin determinant. Eur. J. Immunol. 20:2431-2437.
37. Nikolic-Zugic, J., and R. Dyall. 1993. Positive selection of the T-cell repertoire is affected by mutations in the peptide-binding site of MHC class I molecules. Ann. NY Acad. Sci. 681:16-24.
38. Dyall, R., D.H. Fremont, S.C. Jameson, and J. Nikolic-Zugic. 1996. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC congormational variation. J. Exp. Med. 184:253-258.
39. Jackson, M.R., E.S. Song, Y. Yang, and P.A. Peterson. 1992. Empty and peptide-containing conformers of class I major histocompatibility comples molecules expressed in Drosophila melanogaster cells. Proc. Natl. Acad. Sci. USA. 39:12117-12121.
40. Matsumura, M., Y. Saito, M.R. Jackson, E.S. Song, and P.A. Peterson. 1992. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J. Biol. Chem. 267:23589-23595.
41. Aldrich, C.J., A. DeCloux, A.S. Woods, R.J. Cotter, M.J. Soloski, and J. Forman. 1994. Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class 1b antigen. Cell. 79:649-658.
42. Malarkannan, S., M. Afkarian, and M. Shastri. 1995. A rare cryptic translation product is presented by major histocompatibility complex Class I molecule to alloreactive T cells. J. Exp. Med. 182:1739-1750.
43. Poindexter, N.J., B. Naziruddin, D.W. McCourt, and T. Mohanakumar. 1995. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J. Immunol. 154:3880-3887.
44. Janeway, C.A., Jr. 1991. The co-receptor function of CD4. Seminars Immunol. 3:153-160.
45. Janeway, C.A. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674.
46. Gavin, M.A., and M.J. Bevan. 1995. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity. 3:793-800.
47. Mullbacher, A., A.B. Hill, R.V. Blanden, W.B. Cowden, NJ.C. King, and R. Tha Hla. 1991. Alloreactive cytotoxic T cells recognize MHC Class I antigen without peptide specificity. J. Immunol. 147:1765-1772.
48. Weintraub, B.C., M.R. Jackson, and S.M. Hedrick. 1994. γδ T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J. Immunol. 153:3051-3057.
49. Chattopadhyay, S., M. Theobald, J. Biggs, and L.A. Sherman. 1994. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 179:213-219.
50. Alexander, M.A., C.A. Damico, K.M. Wieties, T.H. Hansen, and J.M. Connolly. 1991. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes. J. Exp. Med. 173:849-58.
51. Goldstein, S.A., and M.F. Mescher. 1987. Cytotoxic T cell activation by class I protein on cell-size artificial membranes: antigen density and Lyt-2/3 function. J. Immunol. 138:2034-2043.
52. Shimonkevitz, R., B. Leuscher, J.-C. Cerottini, and R.H. MacDonald. 1985. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. J. Immonol. 135:892-899.
53. Xu, S., K. Ariizumi, G. Caceres-Dittmar, D. Edelbaum, K. Hashimoto, P.R. Bergstresser, and A. Takashima. 1995. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 154:2697-2705.
54. Rosenberg, A.S., and A. Singer. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10:333-358.
55. + T cell recognition of class II MHC molecules. J. Immunol. 154:5153-5164.
56. Benichou, G., E. Fedoseyeva, P.V. Lehmann, C.A. Olson, M.H. Geysen, M. McMillan, and E.E. Sercarz. 1994. Limited T cell response to donor MHC peptides during allograft rejection - implications for selective immune therapy in transplantation. J. Immunol. 153:938-945.